Gemmer Asset Management LLC Gilead Sciences, Inc. Transaction History

Gemmer Asset Management LLC

$922 Million
Q2 2024

A detailed history of Gemmer Asset Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Gemmer Asset Management LLC holds 3,938 shares of GILD stock, worth $330,595. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,938

Holding current value

$330,595

% of portfolio

0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	BUY	$63.15 - $72.88 $248,684 - $287,001	3,938 New	3,938 $270,000
Q2 2022 Jul 22, 2022	SELL	$57.72 - $65.01 $59,278 - $66,765	-1,027 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$57.92 - $72.58 $1,448 - $1,814	-25 Reduced 2.38%	1,027 $61,000
Q4 2021 Jan 21, 2022	BUY	$64.88 - $73.64 $194 - $220	3 Added 0.29%	1,052 $76,000
Q3 2021 Oct 19, 2021	BUY	$67.69 - $73.03 $203 - $219	3 Added 0.29%	1,049 $73,000
Q2 2021 Jul 23, 2021	BUY	$63.47 - $69.35 $1,459 - $1,595	23 Added 2.25%	1,046 $72,000
Q1 2021 Apr 20, 2021	BUY	$60.0 - $68.46 $60 - $68	1 Added 0.1%	1,023 $66,000
Q4 2020 Jan 28, 2021	SELL	$56.65 - $64.55 $4,701 - $5,357	-83 Reduced 7.51%	1,022 $60,000
Q3 2020 Oct 21, 2020	BUY	$62.1 - $78.08 $62 - $78	1 Added 0.09%	1,105 $70,000
Q2 2020 Jul 31, 2020	BUY	$72.34 - $84.0 $8,102 - $9,408	112 Added 11.29%	1,104 $85,000
Q1 2020 May 01, 2020	BUY	$62.63 - $80.22 $9,206 - $11,792	147 Added 17.4%	992 $74,000
Q4 2019 Jan 17, 2020	SELL	$61.62 - $67.78 $739 - $813	-12 Reduced 1.4%	845 $55,000
Q3 2019 Oct 11, 2019	BUY	$62.51 - $69.0 $875 - $966	14 Added 1.66%	857 $54,000
Q2 2019 Jul 18, 2019	BUY	$61.87 - $69.38 $61 - $69	1 Added 0.12%	843 $57,000
Q1 2019 Apr 17, 2019	SELL	$62.53 - $70.05 $5,315 - $5,954	-85 Reduced 9.17%	842 $55,000
Q4 2018 Jan 18, 2019	SELL	$60.54 - $79.0 $544 - $711	-9 Reduced 0.96%	927 $58,000
Q3 2018 Oct 12, 2018	SELL	$71.28 - $78.92 $6,985 - $7,734	-98 Reduced 9.48%	936 $72,000
Q2 2018 Jul 18, 2018	SELL	$64.88 - $75.68 $389 - $454	-6 Reduced 0.58%	1,034 $73,000
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $13,256 - $16,161	-182 Reduced 14.89%	1,040 $78,000
Q4 2017 Jan 16, 2018	BUY	$71.15 - $83.52 $10,885 - $12,778	153 Added 14.31%	1,222 $88,000
Q3 2017 Oct 12, 2017	BUY	$72.11 - $85.47 $77,085 - $91,367	1,069	1,069 $87,000

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gemmer Asset Management LLC with notifications on news.

Account

Gemmer Asset Management LLC Gilead Sciences, Inc. Transaction History